Navigation Links
Novelos Therapeutics To Present At The Benchmark 2012 Micro Cap Discovery Investor Conference On November 29
Date:11/27/2012

MADISON, Wis., Nov. 27, 2012 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that Harry Palmin, President and CEO of Novelos, will present a corporate update at the Benchmark 2012 Micro Cap Discovery Investor Conference on Thursday, November 29, 2012.  Mr. Palmin is scheduled to present at 10:00 a.m. CT.  The conference will take place at the InterContinental Hotel in Milwaukee and is being sponsored by Benchmark Company, LLC.

A live webcast of the Novelos presentation may be accessed via www.novelos.com
The webcast will be archived for 90 days following the presentation.

About Novelos Therapeutics, Inc.
We are a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer.  Our cancer-targeted compounds are selectively taken up and retained in cancer cells, including cancer stem cells, versus normal cells.  Thus, our therapeutic compounds appear to directly kill cancer cells while minimizing harm to normal cells.  This offers the potential for a paradigm shift in cancer therapy by providing efficacy versus all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse.  I-124-CLR1404 (LIGHT) is a small-molecule, broad-spectrum, cancer-targeted PET imaging agent.  We believe LIGHT has first-in-class potential and Phase 1-2 clinical trials are ongoing across 11 solid tumor indications.  I-131-CLR1404 (HOT) is a small-molecule, broad-spectrum, cancer-targeted molecular radiotherapeutic that delivers cytotoxic radiation directly and selectively to cancer cells and cancer stem cells.  We believe HOT also has first-in-class potential.  HOT Phase 1b dose-escalation trial is ongoing and, subject to additional funding, we expect HOT to enter Phase 2 trials in the third quarter
'/>"/>

SOURCE Novelos Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. Novelos Therapeutics Prices $5.4 Million Public Offering
4. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
5. Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11
6. Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
7. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
8. Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
9. Novelos Therapeutics Closes $2 Million Private Placement
10. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
11. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015 Research and Markets ... "Investigation Report on China,s Tobramycin Market, 2010-2019" ... traditional antibiotic whose eye drop and ointment are the ... infection or inflammation caused by eye infection. Currently, dozens ... able to produce tobramycin, among which the Top 5 ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by Pharmacia & ... receptor agonist which effectively reduces intraocular pressure. As ... latanoprost (under the trade name of Xalatan) entered ...
(Date:8/28/2015)...  Perrigo Company plc ("Perrigo") (NYSE: PRGO ; ... of leading OTC brands from GSK in an all ... a clear demonstration of Perrigo,s unique ability to maximize ... spanning 36 countries.  Perrigo Chairman, President ... are excited to complete this transaction, which clearly demonstrates ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Latanoprost Market Investigation Report 2015-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... FRANCISCO, Nov. 13 Quantros, a leading software ... that it has partnered with Det Norske Veritas ... by the Centers for Medicare and Medicaid Services ... now integrate that company,s accreditation standards into the ...
... Nov. 13 /PRNewswire/ Millar Instruments, Inc., developer and ... (P-V) systems, and Transonic Systems, Inc., global leader ... measurement devices, today announce a new distribution partnership. ... giants in the field of physiological measurements, Transonic ...
Cached Medicine Technology:Quantros Announces Partnership With Hospital Accreditation Agency DNV 2Millar Instruments and Transonic Systems, Suppliers of Gold Standard Pressure and Flow Products, Enter Into Mutual Distribution Agreement 2
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of Workforce Investment ... position they are applying for, they are unable to pass the initial drug test ... drug testing policies in order to be able to hire long-term, skilled talent. (1) ...
(Date:8/28/2015)... Church, VA (PRWEB) , ... ... ... Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and Best ... Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally renowned ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... who might personally be struggling with chemical dependency, may be able to find ... Rehabilitation, a results-driven holistic treatment center for addiction located in Western Michigan. Focusing ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... nationwide. Addictions specialist, Dr. James Strawbridge, gives a new approach on solutions in ... should begin with the employer and employees getting together for meaningful group meetings. ...
(Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, ... radiating pain resulting in shoulder pain, hip pain, neck pain, stiffness, muscle ... Engineering from the University of Illinois, and then went on to earn his title ...
Breaking Medicine News(10 mins):Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3
... impose a huge burden on industrialized societies, in terms ... costs related to back pain in the United States ... year. , But a systematic review of the literature ... of The Spine Journal finds exercise in ...
... The Sher Institutes of Reproductive Medicine (SIRM) announced today ... Plan that guarantees qualified IVF patients a baby ... medical fees. CGH is an acronym for Comparative Genomic ... egg or embryo prior to it being transferred to a ...
... (SCA), one of the country,s largest providers of specialty ... a joint venture relationship with Hawaii Pacific Health to ... downtown Honolulu.Under the terms of the partnership, SCA will ... at 550 South Beretania Street to a new location ...
... Calif., March 5 Grubb & Ellis Healthcare ... Medical Office Buildings Portfolio, an aggregate of four ... area. With buildings in Menomonee Falls, Milwaukee, ... 185,000 square feet of gross leaseable area. "This ...
... 5 Karen Ignagni, President and CEO of America,s ... the White House Health Care Summit:"We were honored to ... bringing together a broad range of policymakers and stakeholders ... President has initiated a transparent, inclusive reform process just ...
... ROCKVILLE, Md., March 5 Americans and nonprofit organizations ... of these circumstances, The Larry King Cardiac Foundation (LKCF), ... for individuals with no health insurance, has announced that ... 2009.In lieu of its annual black tie gala held ...
Cached Medicine News:Health News:Clinical trials' review finds only exercise to prevent low-back problems 2Health News:New DNA Test Is Basis for Groundbreaking IVF Refund Plan, Easing Financial Burden for Patients 2Health News:New DNA Test Is Basis for Groundbreaking IVF Refund Plan, Easing Financial Burden for Patients 3Health News:Surgical Care Affiliates and Hawaii Pacific Health to Operate Surgery Center 2Health News:Grubb & Ellis Healthcare REIT Acquires 185,000 SF Wisconsin Medical Office Buildings Portfolio 2Health News:Grubb & Ellis Healthcare REIT Acquires 185,000 SF Wisconsin Medical Office Buildings Portfolio 3Health News:The Larry King Cardiac Foundation Brings its Annual Gala to Homes Across the Nation 2Health News:The Larry King Cardiac Foundation Brings its Annual Gala to Homes Across the Nation 3
... This therapeutic system ... the patient in mind. ... surgery and ongoing therapy, ... low-risk and effective therapy. ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
... not only one of the most modern lithotripters ... Apart from being designed for the treatment of ... tract, the MODULITH SLX can also be employed ... is equally suitable for the treatment of gallstones ...
... STORZ MEDICAL is the result of many ... of kidney stone lithotripsy and the successful ... met by orthopaedic apparatus for extracorporeal shock ... The MINILITH SL1 is characterized by its ...
Medicine Products: